Trimethoprim and rifampin in combination for chemoprophylaxis of household contacts of patients with invasive infections due to Haemophilus influenzae type b.

AUTOR(ES)

Daum, R S

RESUMO

We compared the effectiveness of rifampin-trimethoprim in fixed combination (3.75:1) to rifampin alone in the eradication of Haemophilus influenzae type b carriage among contacts of patients with invasive infection caused by this organism. The study population was composed of 127 index patients and 620 contacts. Twenty-six percent of contacts were colonized. Rifampin-trimethoprim eradicated carriage in 77.6% of contacts (71.1% in contacts less than 5 years, 84.2% in contacts greater than or equal to 5 years) whereas rifampin eradicated carriage in 69.9% of contacts (56.4% in contacts less than 5 years, 81.8% in contacts greater than or equal to 5 years). A single isolate resistant to rifampin and rifampin-trimethoprim was encountered. The eradication rate achieved with this regimen of rifampin-trimethoprim was too low to recommend its routine use. However, a higher dose or longer course might merit clinical trial.

Documentos Relacionados

• Duration of rifampin chemoprophylaxis for contacts of patients infected with Haemophilus influenzae type B.
• Bilateral empyema and purulent pericarditis due to Haemophilus influenzae capsular type b.
• Bilateral empyema and purulent pericarditis due to Haemophilus influenzae capsular type b.
• In vitro development of rifampin resistance in clinical isolates of Haemophilus influenzae type b.
• Haemophilus influenzae type b.